Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	peptide lactyltransferase (CoA-dependent) activity	CREBBP EP300	1.08e-05	2	66	2	GO:0120300
GeneOntologyMolecularFunction	histone H3K27 acetyltransferase activity	CREBBP EP300	1.08e-05	2	66	2	GO:0044017
GeneOntologyMolecularFunction	histone H3K18 acetyltransferase activity	CREBBP EP300	3.22e-05	3	66	2	GO:0043993
GeneOntologyMolecularFunction	ribosome binding	NOMO2 SLFN14 TTC5 NOMO3 NOMO1	4.81e-05	120	66	5	GO:0043022
GeneOntologyMolecularFunction	cytoskeletal protein binding	MYH10 MYH11 MYL4 ANK2 BAIAP2L1 STARD9 SYNE2 KIF14 RABGAP1 PLS1 EP300 NME8	2.27e-04	1099	66	12	GO:0008092
GeneOntologyMolecularFunction	unmethylated CpG binding	KMT2B KDM2A	4.76e-04	10	66	2	GO:0045322
GeneOntologyMolecularFunction	ribonucleoprotein complex binding	NOMO2 SLFN14 TTC5 NOMO3 NOMO1	5.97e-04	206	66	5	GO:0043021
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH10 MYH11 STARD9 KIF14	6.30e-04	118	66	4	GO:0003774
GeneOntologyMolecularFunction	histone acetyltransferase activity	OGA CREBBP EP300	6.41e-04	51	66	3	GO:0004402
GeneOntologyMolecularFunction	peptide-lysine-N-acetyltransferase activity	OGA CREBBP EP300	8.00e-04	55	66	3	GO:0061733
GeneOntologyMolecularFunction	ATP-dependent activity	BPTF MYH10 MYH11 ATP2C1 STARD9 DDX42 KIF14 DHX32	9.12e-04	614	66	8	GO:0140657
GeneOntologyMolecularFunction	histone modifying activity	KMT2B KDM2A OGA CREBBP EP300	9.61e-04	229	66	5	GO:0140993
GeneOntologyMolecularFunction	peptide N-acetyltransferase activity	OGA CREBBP EP300	1.03e-03	60	66	3	GO:0034212
GeneOntologyMolecularFunction	histone H3 acetyltransferase activity	CREBBP EP300	1.10e-03	15	66	2	GO:0010484
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	CREBBP EP300	2.17e-03	21	66	2	GO:0042975
GeneOntologyMolecularFunction	N-acetyltransferase activity	OGA CREBBP EP300	2.20e-03	78	66	3	GO:0008080
GeneOntologyMolecularFunction	chromatin binding	SP3 MTA1 HOXD10 RBL1 PER1 TTC5 CREBBP EP300	2.93e-03	739	66	8	GO:0003682
GeneOntologyMolecularFunction	transcription factor binding	BDP1 BPTF SP3 MTA1 PER1 SPOP CREBBP EP300	3.28e-03	753	66	8	GO:0008134
GeneOntologyBiologicalProcess	multi-pass transmembrane protein insertion into ER membrane	NOMO2 NOMO3 NOMO1	2.48e-06	9	65	3	GO:0160063
GeneOntologyBiologicalProcess	N-terminal peptidyl-lysine acetylation	CREBBP EP300	5.84e-05	4	65	2	GO:0018076
GeneOntologyBiologicalProcess	positive regulation of protein localization	MYH10 ATP2C1 NPEPPS STAC3 OGA CREBBP PLS1 EP300 ITPR1	9.37e-05	591	65	9	GO:1903829
GeneOntologyBiologicalProcess	membrane organization	MYH10 ATP2C1 ANK2 BAIAP2L1 NOMO2 AHNAK ATG2B ITGA2 NOMO3 EXOC8 NOMO1	1.22e-04	914	65	11	GO:0061024
GeneOntologyBiologicalProcess	protein insertion into ER membrane	NOMO2 NOMO3 NOMO1	1.26e-04	31	65	3	GO:0045048
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO2 NOMO3 NOMO1	2.49e-06	9	66	3	GO:0160064
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO2 NOMO3 NOMO1	1.07e-05	14	66	3	GO:0072379
GeneOntologyCellularComponent	A band	MYL4 ANK2 CMYA5 RPL7	2.19e-05	52	66	4	GO:0031672
GeneOntologyCellularComponent	contractile muscle fiber	MYH11 MYL4 ANK2 AHNAK SYNE2 CMYA5 RPL7	3.56e-05	290	66	7	GO:0043292
GeneOntologyCellularComponent	costamere	ANK2 AHNAK CMYA5	4.43e-05	22	66	3	GO:0043034
GeneOntologyCellularComponent	myosin II complex	MYH10 MYH11 MYL4	9.31e-05	28	66	3	GO:0016460
GeneOntologyCellularComponent	myofibril	MYL4 ANK2 AHNAK SYNE2 CMYA5 RPL7	2.21e-04	273	66	6	GO:0030016
GeneOntologyCellularComponent	sarcoplasm	MYH10 SYNE2 CMYA5 ITPR1	4.66e-04	114	66	4	GO:0016528
GeneOntologyCellularComponent	sperm fibrous sheath	FSCB NME8	7.49e-04	13	66	2	GO:0035686
GeneOntologyCellularComponent	myosin complex	MYH10 MYH11 MYL4	8.61e-04	59	66	3	GO:0016459
GeneOntologyCellularComponent	supramolecular fiber	MYH10 MYH11 MTA1 MYL4 ANK2 AHNAK SYNE2 KIF14 CMYA5 PLS1 RPL7	1.08e-03	1179	66	11	GO:0099512
GeneOntologyCellularComponent	sarcomere	MYL4 ANK2 SYNE2 CMYA5 RPL7	1.14e-03	249	66	5	GO:0030017
GeneOntologyCellularComponent	supramolecular polymer	MYH10 MYH11 MTA1 MYL4 ANK2 AHNAK SYNE2 KIF14 CMYA5 PLS1 RPL7	1.14e-03	1187	66	11	GO:0099081
GeneOntologyCellularComponent	T-tubule	ANK2 AHNAK STAC3	2.00e-03	79	66	3	GO:0030315
GeneOntologyCellularComponent	perinuclear region of cytoplasm	BPTF ANK2 UPF2 ITGA2 CMYA5 DOCK6 PRDX6 EXOC8 ITPR1	2.57e-03	934	66	9	GO:0048471
GeneOntologyCellularComponent	transcription regulator complex	BDP1 SP3 MTA1 HOXD10 RBL1 CREBBP EP300	2.69e-03	596	66	7	GO:0005667
GeneOntologyCellularComponent	sarcoplasmic reticulum	SYNE2 CMYA5 ITPR1	2.72e-03	88	66	3	GO:0016529
GeneOntologyCellularComponent	myosin filament	MYH10 MYH11	2.81e-03	25	66	2	GO:0032982
HumanPheno	Absent earlobe	KMT2B ZNF407 CREBBP EP300	3.33e-06	20	28	4	HP:0000387
HumanPheno	Broad eyebrow	BPTF TTC5 CREBBP EP300	1.58e-05	29	28	4	HP:0011229
HumanPheno	Prominent nose	BPTF SPOP TTC5 CREBBP EP300 ITPR1	2.26e-05	110	28	6	HP:0000448
HumanPheno	Plantar crease between first and second toes	CREBBP EP300	2.91e-05	2	28	2	HP:0008107
HumanPheno	Aortic isthmus hypoplasia	CREBBP EP300	2.91e-05	2	28	2	HP:0034227
HumanPheno	High axial triradius	CREBBP EP300	2.91e-05	2	28	2	HP:0001042
HumanPheno	Overlapping toe	BPTF ZNF407 CREBBP NEK9 EP300	3.74e-05	72	28	5	HP:0001845
HumanPheno	Laryngeal cartilage malformation	CREBBP EP300	8.71e-05	3	28	2	HP:0008752
HumanPheno	Phobia	CREBBP EP300	8.71e-05	3	28	2	HP:5200232
HumanPheno	Agoraphobia	CREBBP EP300	8.71e-05	3	28	2	HP:0000756
HumanPheno	Humoral immunodeficiency	CREBBP EP300	8.71e-05	3	28	2	HP:0005363
HumanPheno	Prominent nasal septum	CREBBP EP300	8.71e-05	3	28	2	HP:0005322
HumanPheno	Radial deviation of thumb terminal phalanx	CREBBP EP300	8.71e-05	3	28	2	HP:0005895
HumanPheno	Delayed ability to stand	ZNF407 TTC5 ITPR1	9.61e-05	17	28	3	HP:0025335
HumanPheno	Trichiasis	CREBBP EP300	1.74e-04	4	28	2	HP:0001128
HumanPheno	Visceral hemangioma	CREBBP EP300	1.74e-04	4	28	2	HP:0410266
HumanPheno	Talon cusp	CREBBP EP300	1.74e-04	4	28	2	HP:0011087
HumanPheno	Widened distal phalanges	CREBBP EP300	1.74e-04	4	28	2	HP:0006200
HumanPheno	Vascular ring	CREBBP EP300	1.74e-04	4	28	2	HP:0010775
HumanPheno	Hepatic hemangioma	CREBBP EP300	1.74e-04	4	28	2	HP:0031207
HumanPheno	Aplasia/Hypoplasia of the earlobes	KMT2B ZNF407 CREBBP EP300	1.78e-04	53	28	4	HP:0009906
HumanPheno	Papillary cystadenoma of the epididymis	CREBBP EP300	2.88e-04	5	28	2	HP:0009715
HumanPheno	Supernumerary cusp	CREBBP EP300	2.88e-04	5	28	2	HP:0033777
HumanPheno	Epididymal neoplasm	CREBBP EP300	2.88e-04	5	28	2	HP:0030421
HumanPheno	Large foramen magnum	CREBBP EP300	4.31e-04	6	28	2	HP:0002700
HumanPheno	Short palpebral fissure	BPTF STAC3 CREBBP EP300 SLX4	4.59e-04	122	28	5	HP:0012745
HumanPheno	Avascular necrosis of the capital femoral epiphysis	CREBBP NEK9 EP300	5.47e-04	30	28	3	HP:0005743
HumanPheno	Abnormal pulmonary valve morphology	BPTF DOCK6 CREBBP NEK9 EP300 ITPR1	5.88e-04	198	28	6	HP:0001641
HumanPheno	Toe deformity	BPTF ZNF407 CREBBP NEK9 EP300	5.93e-04	129	28	5	HP:0034398
HumanPheno	Deviated nasal septum	CREBBP EP300	6.02e-04	7	28	2	HP:0004411
HumanPheno	Broad hallux	BPTF KMT2B CREBBP EP300	7.14e-04	76	28	4	HP:0010055
HumanPheno	Facial hypertrichosis	BPTF ZNF407 SPOP CREBBP CWF19L1 EP300	7.26e-04	206	28	6	HP:0002219
HumanPheno	Pulmonic stenosis	BPTF CREBBP NEK9 EP300 ITPR1	8.07e-04	138	28	5	HP:0001642
Domain	DUF2012	NOMO2 NOMO3 NOMO1	1.53e-07	4	64	3	PF09430
Domain	DUF2012	NOMO2 NOMO3 NOMO1	1.53e-07	4	64	3	IPR019008
Domain	Bromodomain_CS	BPTF BAZ2B CREBBP EP300	1.77e-06	26	64	4	IPR018359
Domain	Carb-bd-like_fold	NOMO2 NOMO3 NOMO1	2.12e-06	8	64	3	IPR013784
Domain	Znf_PHD-finger	BPTF KMT2B BAZ2B PHF3 KDM2A	7.47e-06	79	64	5	IPR019787
Domain	BROMODOMAIN_1	BPTF BAZ2B CREBBP EP300	7.61e-06	37	64	4	PS00633
Domain	Bromodomain	BPTF BAZ2B CREBBP EP300	8.48e-06	38	64	4	PF00439
Domain	CarboxyPept_regulatory_dom	NOMO2 NOMO3 NOMO1	1.07e-05	13	64	3	IPR014766
Domain	-	NOMO2 NOMO3 NOMO1	1.07e-05	13	64	3	2.60.40.1120
Domain	BROMODOMAIN_2	BPTF BAZ2B CREBBP EP300	1.15e-05	41	64	4	PS50014
Domain	Nuc_rcpt_coact_CREBbp	CREBBP EP300	1.16e-05	2	64	2	IPR014744
Domain	HAT_KAT11	CREBBP EP300	1.16e-05	2	64	2	PF08214
Domain	KIX	CREBBP EP300	1.16e-05	2	64	2	PS50952
Domain	ZnF_TAZ	CREBBP EP300	1.16e-05	2	64	2	SM00551
Domain	CBP_P300_HAT	CREBBP EP300	1.16e-05	2	64	2	IPR031162
Domain	DUF902	CREBBP EP300	1.16e-05	2	64	2	PF06001
Domain	-	CREBBP EP300	1.16e-05	2	64	2	1.20.1020.10
Domain	RING_CBP-p300	CREBBP EP300	1.16e-05	2	64	2	IPR010303
Domain	-	CREBBP EP300	1.16e-05	2	64	2	1.10.1630.10
Domain	Creb_binding	CREBBP EP300	1.16e-05	2	64	2	PF09030
Domain	-	CREBBP EP300	1.16e-05	2	64	2	1.10.246.20
Domain	zf-TAZ	CREBBP EP300	1.16e-05	2	64	2	PF02135
Domain	ZF_TAZ	CREBBP EP300	1.16e-05	2	64	2	PS50134
Domain	Histone_AcTrfase_Rtt109/CBP	CREBBP EP300	1.16e-05	2	64	2	IPR013178
Domain	KAT11	CREBBP EP300	1.16e-05	2	64	2	SM01250
Domain	Znf_TAZ	CREBBP EP300	1.16e-05	2	64	2	IPR000197
Domain	KIX_dom	CREBBP EP300	1.16e-05	2	64	2	IPR003101
Domain	KIX	CREBBP EP300	1.16e-05	2	64	2	PF02172
Domain	CBP_P300_HAT	CREBBP EP300	1.16e-05	2	64	2	PS51727
Domain	BROMO	BPTF BAZ2B CREBBP EP300	1.27e-05	42	64	4	SM00297
Domain	Bromodomain	BPTF BAZ2B CREBBP EP300	1.27e-05	42	64	4	IPR001487
Domain	-	BPTF BAZ2B CREBBP EP300	1.27e-05	42	64	4	1.20.920.10
Domain	PHD	BPTF KMT2B BAZ2B PHF3 KDM2A	1.34e-05	89	64	5	SM00249
Domain	Znf_PHD	BPTF KMT2B BAZ2B PHF3 KDM2A	1.49e-05	91	64	5	IPR001965
Domain	ZF_PHD_2	BPTF KMT2B BAZ2B PHF3 KDM2A	1.84e-05	95	64	5	PS50016
Domain	ZF_PHD_1	BPTF KMT2B BAZ2B PHF3 KDM2A	1.94e-05	96	64	5	PS01359
Domain	CarboxyPept-like_regulatory	NOMO2 NOMO3 NOMO1	2.52e-05	17	64	3	IPR008969
Domain	DDT	BPTF BAZ2B	6.90e-05	4	64	2	PF02791
Domain	DDT	BPTF BAZ2B	1.15e-04	5	64	2	SM00571
Domain	WSD	BPTF BAZ2B	1.15e-04	5	64	2	PF15613
Domain	Myosin_S1_N	MYH10 MYH11	1.15e-04	5	64	2	IPR008989
Domain	DDT_dom	BPTF BAZ2B	1.15e-04	5	64	2	IPR018501
Domain	WHIM2_dom	BPTF BAZ2B	1.15e-04	5	64	2	IPR028941
Domain	FHA	STARD9 MKI67 KIF14	1.18e-04	28	64	3	SM00240
Domain	PHD	BPTF KMT2B BAZ2B PHF3	1.27e-04	75	64	4	PF00628
Domain	Znf_FYVE_PHD	BPTF KMT2B BAZ2B PHF3 KDM2A	1.48e-04	147	64	5	IPR011011
Domain	FHA	STARD9 MKI67 KIF14	1.61e-04	31	64	3	PF00498
Domain	DDT	BPTF BAZ2B	1.72e-04	6	64	2	PS50827
Domain	Nuc_rcpt_coact	CREBBP EP300	1.72e-04	6	64	2	IPR009110
Domain	FHA_dom	STARD9 MKI67 KIF14	2.53e-04	36	64	3	IPR000253
Domain	-	STARD9 MKI67 KIF14	2.53e-04	36	64	3	2.60.200.20
Domain	Znf_CXXC	KMT2B KDM2A	6.23e-04	11	64	2	IPR002857
Domain	ZF_CXXC	KMT2B KDM2A	6.23e-04	11	64	2	PS51058
Domain	zf-CXXC	KMT2B KDM2A	6.23e-04	11	64	2	PF02008
Domain	SMAD_FHA_domain	STARD9 MKI67 KIF14	7.52e-04	52	64	3	IPR008984
Domain	Myosin_N	MYH10 MYH11	1.18e-03	15	64	2	PF02736
Domain	Myosin_N	MYH10 MYH11	1.18e-03	15	64	2	IPR004009
Domain	Zinc_finger_PHD-type_CS	BPTF PHF3 KDM2A	1.44e-03	65	64	3	IPR019786
Domain	Myosin_tail_1	MYH10 MYH11	1.71e-03	18	64	2	PF01576
Domain	ZZ	CREBBP EP300	1.71e-03	18	64	2	PF00569
Domain	Myosin_tail	MYH10 MYH11	1.71e-03	18	64	2	IPR002928
Domain	ZF_ZZ_2	CREBBP EP300	1.71e-03	18	64	2	PS50135
Domain	ZF_ZZ_1	CREBBP EP300	1.71e-03	18	64	2	PS01357
Domain	Znf_ZZ	CREBBP EP300	1.90e-03	19	64	2	IPR000433
Domain	ZnF_ZZ	CREBBP EP300	1.90e-03	19	64	2	SM00291
Domain	Myosin-like_IQ_dom	MYH10 MYH11	1.90e-03	19	64	2	IPR027401
Domain	-	MYH10 MYH11	1.90e-03	19	64	2	4.10.270.10
Domain	Actinin_actin-bd_CS	SYNE2 PLS1	2.79e-03	23	64	2	IPR001589
Domain	ACTININ_2	SYNE2 PLS1	2.79e-03	23	64	2	PS00020
Domain	ACTININ_1	SYNE2 PLS1	2.79e-03	23	64	2	PS00019
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_CIT	MYH10 MYH11 KIF14	2.84e-05	19	45	3	M27489
Pathway	BIOCARTA_PELP1_PATHWAY	CREBBP EP300	9.90e-05	5	45	2	MM1575
Pathway	REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES	CREBBP EP300	9.90e-05	5	45	2	M48020
Pathway	REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES	CREBBP EP300	9.90e-05	5	45	2	M48023
Pathway	REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION	CREBBP EP300	9.90e-05	5	45	2	M27228
Pathway	PID_SMAD2_3NUCLEAR_PATHWAY	SP3 RBL1 CREBBP EP300	1.32e-04	82	45	4	M2
Pathway	BIOCARTA_PELP1_PATHWAY	CREBBP EP300	1.48e-04	6	45	2	M22062
Pathway	KEGG_MEDICUS_REFERENCE_DOUBLE_HOLLIDAY_JUNCTION_RESOLUTION	GEN1 SLX4	1.48e-04	6	45	2	M47839
Pathway	BIOCARTA_PPARG_PATHWAY	CREBBP EP300	2.07e-04	7	45	2	MM1573
Pathway	BIOCARTA_PPARG_PATHWAY	CREBBP EP300	2.76e-04	8	45	2	M22058
Pathway	REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES	CREBBP EP300	2.76e-04	8	45	2	M48022
Pathway	REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION	CREBBP EP300	2.76e-04	8	45	2	M48024
Pathway	REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES	CREBBP EP300	2.76e-04	8	45	2	M46443
Pathway	KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY	CREBBP EP300	3.54e-04	9	45	2	M47451
Pathway	REACTOME_CGMP_EFFECTS	PDE10A ITPR1	4.41e-04	10	45	2	MM15054
Pathway	REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION	CREBBP EP300	4.41e-04	10	45	2	M27945
Pathway	BIOCARTA_CARM1_PATHWAY	CREBBP EP300	5.38e-04	11	45	2	MM1521
Pathway	REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES	CREBBP EP300	5.38e-04	11	45	2	M48021
Pathway	REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR	CREBBP EP300	5.38e-04	11	45	2	M26924
Pathway	BIOCARTA_CARM1_PATHWAY	CREBBP EP300	6.44e-04	12	45	2	M7968
Pathway	REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS	CREBBP EP300	6.44e-04	12	45	2	M27765
Pathway	KEGG_CELL_CYCLE	ORC6 RBL1 CREBBP EP300	6.63e-04	125	45	4	M7963
Pathway	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	PDE10A ITPR1	7.60e-04	13	45	2	MM15015
Pathway	PID_P53_REGULATION_PATHWAY	TTC5 CREBBP EP300	8.72e-04	59	45	3	M261
Pathway	REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING	CREBBP EP300	8.85e-04	14	45	2	M27808
Pathway	BIOCARTA_RELA_PATHWAY	CREBBP EP300	1.02e-03	15	45	2	MM1339
Pathway	BIOCARTA_RELA_PATHWAY	CREBBP EP300	1.02e-03	15	45	2	M10183
Pathway	BIOCARTA_PITX2_PATHWAY	CREBBP EP300	1.02e-03	15	45	2	MM1439
Pathway	REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY	CREBBP EP300	1.02e-03	15	45	2	M953
Pathway	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS	CREBBP EP300	1.16e-03	16	45	2	M27121
Pathway	BIOCARTA_IL7_PATHWAY	CREBBP EP300	1.16e-03	16	45	2	M1296
Pathway	REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS	SP3 MTA1	1.16e-03	16	45	2	MM14938
Pathway	BIOCARTA_IL7_PATHWAY	CREBBP EP300	1.16e-03	16	45	2	MM1420
Pathway	BIOCARTA_PITX2_PATHWAY	CREBBP EP300	1.16e-03	16	45	2	M8516
Pathway	REACTOME_CGMP_EFFECTS	PDE10A ITPR1	1.16e-03	16	45	2	M902
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES	CREBBP EP300	1.16e-03	16	45	2	M27940
Pathway	BIOCARTA_TGFB_PATHWAY	CREBBP EP300	1.31e-03	17	45	2	MM1509
Pathway	REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA	CREBBP EP300	1.31e-03	17	45	2	M48025
Pathway	KEGG_LONG_TERM_POTENTIATION	CREBBP EP300 ITPR1	1.43e-03	70	45	3	M3115
Pathway	REACTOME_CIRCADIAN_CLOCK	PER1 CREBBP EP300	1.43e-03	70	45	3	M938
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION	TTC5 EP300	1.48e-03	18	45	2	MM15342
Pathway	REACTOME_RORA_ACTIVATES_GENE_EXPRESSION	CREBBP EP300	1.48e-03	18	45	2	M26942
Pathway	REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST	RBL1 EP300	1.48e-03	18	45	2	M27633
Pathway	PID_E2F_PATHWAY	RBL1 CREBBP EP300	1.62e-03	73	45	3	M40
Pathway	BIOCARTA_TGFB_PATHWAY	CREBBP EP300	1.65e-03	19	45	2	M18933
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION	TTC5 EP300	1.65e-03	19	45	2	M27639
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_ROCKS	MYH10 MYH11	1.65e-03	19	45	2	M27493
Pathway	REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES	CREBBP EP300	1.65e-03	19	45	2	M46442
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	MTA1 KMT2B KDM2A CREBBP EP300	1.68e-03	272	45	5	M29619
Pathway	REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE	MYH10 MYH11	1.83e-03	20	45	2	M18415
Pathway	REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	CREBBP EP300	1.83e-03	20	45	2	M27881
Pathway	REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS	SP3 MTA1	1.83e-03	20	45	2	M27237
Pathway	WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX	CREBBP EP300	2.01e-03	21	45	2	M39593
Pathway	REACTOME_CD209_DC_SIGN_SIGNALING	CREBBP EP300	2.01e-03	21	45	2	M27485
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_PAKS	MYH10 MYH11	2.01e-03	21	45	2	M27494
Pathway	PID_MYC_ACTIV_PATHWAY	MTA1 CREBBP EP300	2.03e-03	79	45	3	M66
Pathway	BIOCARTA_VDR_PATHWAY	CREBBP EP300	2.21e-03	22	45	2	MM1370
Pathway	BIOCARTA_NTHI_PATHWAY	CREBBP EP300	2.21e-03	22	45	2	MM1443
Pathway	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	PDE10A ITPR1	2.21e-03	22	45	2	M915
Pathway	BIOCARTA_NTHI_PATHWAY	CREBBP EP300	2.42e-03	23	45	2	M2821
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_PAKS	MYH10 MYH11	2.42e-03	23	45	2	MM15222
Pathway	KEGG_TGF_BETA_SIGNALING_PATHWAY	RBL1 CREBBP EP300	2.59e-03	86	45	3	M2642
Pathway	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING	MYH10 MYH11	2.63e-03	24	45	2	M2243
Pathway	BIOCARTA_VDR_PATHWAY	CREBBP EP300	2.63e-03	24	45	2	M13404
Pathway	REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	CREBBP EP300	2.85e-03	25	45	2	M27880
Pathway	REACTOME_SUMOYLATION	SP3 MTA1 CREBBP EP300	3.04e-03	189	45	4	M27214
Pathway	BIOCARTA_CARM_ER_PATHWAY	CREBBP EP300	3.08e-03	26	45	2	M2499
Pathway	PID_HDAC_CLASSIII_PATHWAY	CREBBP EP300	3.08e-03	26	45	2	M32
Pathway	REACTOME_ATTENUATION_PHASE	CREBBP EP300	3.57e-03	28	45	2	M27254
Pathway	REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE	MYH10 MYH11	3.83e-03	29	45	2	M27309
Pathway	PID_RETINOIC_ACID_PATHWAY	CREBBP EP300	4.09e-03	30	45	2	M207
Pathway	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	CREBBP EP300	4.09e-03	30	45	2	M936
Pubmed	An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance.	NOMO2 NEK9 PRDX6 NOMO3 NOMO1	4.80e-09	33	66	5	30783098
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO2 NOMO3 NOMO1	6.53e-09	3	66	3	36011023
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO2 NOMO3 NOMO1	6.53e-09	3	66	3	25576386
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	BPTF KMT2B PHF3 AHNAK ATG2B KIF14 KDM2A CREBBP NEK9 EP300 PRDX6	6.73e-09	549	66	11	38280479
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO2 NOMO3 NOMO1	2.61e-08	4	66	3	31833031
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO2 NOMO3 NOMO1	2.61e-08	4	66	3	9267806
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	BPTF XRN2 MYH10 PHF3 NPEPPS AHNAK SYNE2 DDX42 MKI67 KIF14 RPL7	3.96e-08	653	66	11	22586326
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	BPTF XRN2 MTA1 PHF3 AHNAK DDX42 MKI67 KDM2A RABGAP1 CREBBP CWF19L1 EP300 PRDX6	4.99e-08	1014	66	13	32416067
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	BAIAP2L1 ORC6 RBL1 SYNE2 KDM2A CREBBP PLS1 EP300 RPL7	6.40e-08	398	66	9	35016035
Pubmed	Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation.	SP3 CREBBP EP300	6.51e-08	5	66	3	10362258
Pubmed	Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock.	PER1 CREBBP EP300	1.30e-07	6	66	3	20930143
Pubmed	Sp1 family of transcription factors regulates the human alpha2 (XI) collagen gene (COL11A2) in Saos-2 osteoblastic cells.	SP3 CREBBP EP300	1.30e-07	6	66	3	16734381
Pubmed	Defining the membrane proteome of NK cells.	XRN2 ATP2C1 ORC6 AHNAK DDX42 MKI67 KIF14 OGA RPL7 PRDX6 EXOC8 NOMO1 ITPR1	2.53e-07	1168	66	13	19946888
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	BPTF MTA1 BAZ2B CREBBP EP300	3.28e-07	75	66	5	25593309
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO2 NOMO3 NOMO1	3.63e-07	8	66	3	15257293
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MYH11 ATP2C1 BAZ2B PER1 ZNF407 KDM2A NEK9 SLX4 PRDX6	3.89e-07	493	66	9	15368895
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	MYH10 MTA1 KMT2B BAIAP2L1 PHF3 MKI67 NEK9 PLS1 PRDX6	4.83e-07	506	66	9	30890647
Pubmed	WDFY4 is required for cross-presentation in response to viral and tumor antigens.	MYH10 MYH11 NOMO2 AHNAK NOMO3 NOMO1	5.38e-07	156	66	6	30409884
Pubmed	Substrate-driven assembly of a translocon for multipass membrane proteins.	NOMO2 NOMO3 NOMO1	5.44e-07	9	66	3	36261522
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	BPTF MTA1 KMT2B BAZ2B CREBBP EP300	5.59e-07	157	66	6	30186101
Pubmed	Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q.	MYH11 NOMO2 NOMO3 IQCK NOMO1	9.13e-07	92	66	5	10493829
Pubmed	An ER translocon for multi-pass membrane protein biogenesis.	NOMO2 NOMO3 NOMO1	1.07e-06	11	66	3	32820719
Pubmed	Histone acetyltransferase-dependent chromatin remodeling and the vascular clock.	PER1 CREBBP EP300	1.42e-06	12	66	3	14645221
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	ATP2C1 RBL1 SYNE2 MKI67 KIF14 OGA FSCB CREBBP EP300 ITPR1	1.53e-06	754	66	10	35906200
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	BDP1 XRN2 BAIAP2L1 NOMO2 KIF14 RABGAP1 CRYBG3 CREBBP SLX4	1.67e-06	588	66	9	38580884
Pubmed	Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.	MYH10 MYH11 AHNAK RPL7 NOMO3 NOMO1	1.75e-06	191	66	6	33762435
Pubmed	KASH protein Syne-2/Nesprin-2 and SUN proteins SUN1/2 mediate nuclear migration during mammalian retinal development.	MYH10 SYNE2 MKI67	1.84e-06	13	66	3	21177258
Pubmed	Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation.	MKI67 CREBBP EP300	2.92e-06	15	66	3	14517255
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	NPEPPS AHNAK ATG2B DZIP3 KIF14 KDM2A CREBBP NEK9 EP300	3.54e-06	645	66	9	25281560
Pubmed	Loss of p300 accelerates MDS-associated leukemogenesis.	CREBBP EP300	3.55e-06	2	66	2	27881875
Pubmed	Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia.	CREBBP EP300	3.55e-06	2	66	2	34845315
Pubmed	p300 plays a critical role in maintaining cardiac mitochondrial function and cell survival in postnatal hearts.	CREBBP EP300	3.55e-06	2	66	2	19729597
Pubmed	Endogenous CCAAT/enhancer binding protein beta and p300 are both regulated by growth hormone to mediate transcriptional activation.	CREBBP EP300	3.55e-06	2	66	2	15860545
Pubmed	Constriction velocities of renal afferent and efferent arterioles of mice are not related to SMB expression.	MYH10 MYH11	3.55e-06	2	66	2	16316347
Pubmed	Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein-Taybi syndrome.	CREBBP EP300	3.55e-06	2	66	2	29460469
Pubmed	Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer.	CREBBP EP300	3.55e-06	2	66	2	24551300
Pubmed	Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma.	CREBBP EP300	3.55e-06	2	66	2	33911074
Pubmed	The adenovirus 12 E1A proteins can bind directly to proteins of the p300 transcription co-activator family, including the CREB-binding protein CBP and p300.	CREBBP EP300	3.55e-06	2	66	2	9018065
Pubmed	Coactivators p300 and CBP maintain the identity of mouse embryonic stem cells by mediating long-range chromatin structure.	CREBBP EP300	3.55e-06	2	66	2	24648406
Pubmed	CBP and P300 regulate distinct gene networks required for human primary myoblast differentiation and muscle integrity.	CREBBP EP300	3.55e-06	2	66	2	30135524
Pubmed	CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer.	CREBBP EP300	3.55e-06	2	66	2	39287984
Pubmed	Distribution of co-activators CBP and p300 during mouse oocyte and embryo development.	CREBBP EP300	3.55e-06	2	66	2	16596650
Pubmed	The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation.	CREBBP EP300	3.55e-06	2	66	2	29217654
Pubmed	Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein-Taybi syndrome detected by aCGH.	CREBBP EP300	3.55e-06	2	66	2	20717166
Pubmed	Differences in the interactions of oncogenic adenovirus 12 early region 1A and nononcogenic adenovirus 2 early region 1A with the cellular coactivators p300 and CBP.	CREBBP EP300	3.55e-06	2	66	2	10049825
Pubmed	CBP/p300 acetyltransferase activity in hematologic malignancies.	CREBBP EP300	3.55e-06	2	66	2	27380996
Pubmed	CREBBP and p300 lysine acetyl transferases in the DNA damage response.	CREBBP EP300	3.55e-06	2	66	2	29170789
Pubmed	The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.	CREBBP EP300	3.55e-06	2	66	2	25893291
Pubmed	Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.	CREBBP EP300	3.55e-06	2	66	2	11559821
Pubmed	Crebbp haploinsufficiency in mice alters the bone marrow microenvironment, leading to loss of stem cells and excessive myelopoiesis.	CREBBP EP300	3.55e-06	2	66	2	21555743
Pubmed	CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells.	CREBBP EP300	3.55e-06	2	66	2	12646247
Pubmed	Cholinergic augmentation of insulin release requires ankyrin-B.	ANK2 ITPR1	3.55e-06	2	66	2	20234002
Pubmed	Inositol 1,4,5-trisphosphate receptor localization and stability in neonatal cardiomyocytes requires interaction with ankyrin-B.	ANK2 ITPR1	3.55e-06	2	66	2	14722080
Pubmed	CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas.	CREBBP EP300	3.55e-06	2	66	2	32576962
Pubmed	Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.	CREBBP EP300	3.55e-06	2	66	2	19822209
Pubmed	A specific CBP/p300-dependent gene expression programme drives the metabolic remodelling in late stages of spermatogenesis.	CREBBP EP300	3.55e-06	2	66	2	24522976
Pubmed	Histone acetyltransferase activities of cAMP-regulated enhancer-binding protein and p300 in tissues of fetal, young, and old mice.	CREBBP EP300	3.55e-06	2	66	2	11867645
Pubmed	CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement.	CREBBP EP300	3.55e-06	2	66	2	21847097
Pubmed	p300 Acetylates JHDM1A to inhibit osteosarcoma carcinogenesis.	KDM2A EP300	3.55e-06	2	66	2	31307234
Pubmed	Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue.	CREBBP EP300	3.55e-06	2	66	2	11963968
Pubmed	Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1.	KDM2A CREBBP	3.55e-06	2	66	2	27537276
Pubmed	Antisense-induced knockdown of cAMP response element-binding protein downregulates Per1 gene expression in the shell region of nucleus accumbens resulting in reduced alcohol consumption in mice.	PER1 CREBBP	3.55e-06	2	66	2	34424532
Pubmed	p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes.	CREBBP EP300	3.55e-06	2	66	2	34813504
Pubmed	Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300.	CREBBP EP300	3.55e-06	2	66	2	9528808
Pubmed	Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines.	CREBBP EP300	3.55e-06	2	66	2	12696060
Pubmed	Ankyrin B modulates the function of Na,K-ATPase/inositol 1,4,5-trisphosphate receptor signaling microdomain.	ANK2 ITPR1	3.55e-06	2	66	2	18303017
Pubmed	Rubinstein-Taybi Syndrome	CREBBP EP300	3.55e-06	2	66	2	20301699
Pubmed	CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain.	CREBBP EP300	3.55e-06	2	66	2	36109165
Pubmed	Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue.	MYH10 MYH11	3.55e-06	2	66	2	10906735
Pubmed	Potential biomarker of metformin action.	CREBBP EP300	3.55e-06	2	66	2	24639469
Pubmed	The histone acetyl transferases CBP and p300 regulate stress response pathways in synovial fibroblasts at transcriptional and functional levels.	CREBBP EP300	3.55e-06	2	66	2	37816914
Pubmed	Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300.	CREBBP EP300	3.55e-06	2	66	2	12242694
Pubmed	Binding of p300/CBP co-activators by polyoma large T antigen.	CREBBP EP300	3.55e-06	2	66	2	11438528
Pubmed	Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.	CREBBP EP300	3.55e-06	2	66	2	10918613
Pubmed	CBP/p300 Drives the Differentiation of Regulatory T Cells through Transcriptional and Non-Transcriptional Mechanisms.	CREBBP EP300	3.55e-06	2	66	2	31182547
Pubmed	Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity.	CREBBP EP300	3.55e-06	2	66	2	35502657
Pubmed	Rubinstein-Taybi syndrome in a Saudi boy with distinct features and variants in both the CREBBP and EP300 genes: a case report.	CREBBP EP300	3.55e-06	2	66	2	30635043
Pubmed	p300 and cAMP response element-binding protein-binding protein in skeletal muscle homeostasis, contractile function, and survival.	CREBBP EP300	3.55e-06	2	66	2	31898871
Pubmed	Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities.	OGA EP300	3.55e-06	2	66	2	15485860
Pubmed	Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations.	CREBBP EP300	3.55e-06	2	66	2	27648933
Pubmed	Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity.	CREBBP EP300	3.55e-06	2	66	2	30888860
Pubmed	Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer.	CREBBP EP300	3.55e-06	2	66	2	27881443
Pubmed	Spatiotemporal expression of histone acetyltransferases, p300 and CBP, in developing embryonic hearts.	CREBBP EP300	3.55e-06	2	66	2	19272189
Pubmed	Developmentally regulated expression of the transcriptional cofactors/histone acetyltransferases CBP and p300 during mouse embryogenesis.	CREBBP EP300	3.55e-06	2	66	2	10610021
Pubmed	Emerging roles of p300/CBP in autophagy and autophagy-related human disorders.	CREBBP EP300	3.55e-06	2	66	2	37314181
Pubmed	Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal.	CREBBP EP300	3.55e-06	2	66	2	12397173
Pubmed	CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding.	CREBBP EP300	3.55e-06	2	66	2	15641773
Pubmed	Differential contribution of p300 and CBP to regulatory element acetylation in mESCs.	CREBBP EP300	3.55e-06	2	66	2	32690000
Pubmed	Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein.	CREBBP EP300	3.55e-06	2	66	2	9733868
Pubmed	CBP/p300 antagonises EGFR-Ras-Erk signalling and suppresses increased Ras-Erk signalling-induced tumour formation in mice.	CREBBP EP300	3.55e-06	2	66	2	30953353
Pubmed	Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control.	CREBBP EP300	3.55e-06	2	66	2	21803292
Pubmed	HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter.	CREBBP EP300	3.55e-06	2	66	2	9811832
Pubmed	Two independent regions of simian virus 40 T antigen increase CBP/p300 levels, alter patterns of cellular histone acetylation, and immortalize primary cells.	CREBBP EP300	3.55e-06	2	66	2	24089570
Pubmed	Rubinstein-Taybi syndrome in Chinese population with four novel mutations.	CREBBP EP300	3.55e-06	2	66	2	33063428
Pubmed	EP300/CBP is crucial for cAMP-PKA pathway to alleviate podocyte dedifferentiation via targeting Notch3 signaling.	CREBBP EP300	3.55e-06	2	66	2	34506759
Pubmed	Lack of somatic mutations in the catalytic domains of CREBBP and EP300 genes implies a role for histone deacetylase inhibition in myeloproliferative neoplasms.	CREBBP EP300	3.55e-06	2	66	2	22177454
Pubmed	Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease.	CREBBP EP300	3.55e-06	2	66	2	15706485
Pubmed	AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.	CREBBP EP300	3.55e-06	2	66	2	39266679
Pubmed	A boy with classical Rubinstein-Taybi syndrome but no detectable mutation in the CREBBP and EP300 genes.	CREBBP EP300	3.55e-06	2	66	2	22303793
Pubmed	Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis.	MYH10 MYH11	3.55e-06	2	66	2	7916668
Interaction	HDAC1 interactions	BPTF SP3 MYH10 MTA1 KMT2B RBL1 AHNAK SYNE2 ATG2B MKI67 DZIP3 KIF14 RABGAP1 CRYBG3 CREBBP NEK9 EP300	5.16e-08	1108	65	17	int:HDAC1
Interaction	YAP1 interactions	BPTF XRN2 MYH10 MYH11 KMT2B RBL1 PHF3 NPEPPS AHNAK KIF14 KDM2A CREBBP NEK9 EP300 RPL7 PRDX6	2.70e-07	1095	65	16	int:YAP1
Interaction	LDHA interactions	MYH10 ANK2 UPF2 NPEPPS MKI67 SPOP RABGAP1 EP300 SLX4 PRDX6	3.18e-07	375	65	10	int:LDHA
Interaction	SIN3A interactions	BPTF SP3 MTA1 RBL1 DZIP3 PER1 KIF14 OGA CREBBP EP300	3.59e-07	380	65	10	int:SIN3A
Interaction	DYRK1A interactions	BDP1 MYH11 MTA1 RBL1 AHNAK MKI67 KIF14 DOCK6 CREBBP EP300 SLX4	1.38e-06	552	65	11	int:DYRK1A
Interaction	PHF21A interactions	SP3 KMT2B AHNAK ATG2B DZIP3 KIF14 RABGAP1 CRYBG3 NEK9	1.49e-06	343	65	9	int:PHF21A
Interaction	ACTC1 interactions	MYH10 MTA1 KMT2B BAIAP2L1 PHF3 SYNE2 MKI67 KIF14 NEK9 PLS1 SLX4 PRDX6	1.91e-06	694	65	12	int:ACTC1
Interaction	ENO1 interactions	XRN2 MYH10 MYH11 UPF2 NOMO2 AHNAK KIF14 KDM2A SPOP SLX4 PRDX6 NOMO1	2.12e-06	701	65	12	int:ENO1
Interaction	SNW1 interactions	XRN2 ORC6 RBL1 AHNAK DDX42 MKI67 KIF14 SPOP RABGAP1 CWF19L1 EP300 SLX4	4.08e-06	747	65	12	int:SNW1
Interaction	FUS interactions	XRN2 MYH10 UPF2 PHF3 DDX42 MKI67 KIF14 SPOP GEN1 CREBBP EP300 SLX4	4.67e-06	757	65	12	int:FUS
Interaction	H3C1 interactions	BPTF MYH10 MTA1 KMT2B ANK2 PHF3 AHNAK DDX42 MKI67 KDM2A CREBBP CWF19L1 EP300	4.95e-06	901	65	13	int:H3C1
Interaction	TRPC6 interactions	SP3 NOMO2 NOMO3 NOMO1 ITPR1	6.72e-06	82	65	5	int:TRPC6
Interaction	EXOSC10 interactions	XRN2 UPF2 NOMO2 KIF14 SLX4 NOMO3 NOMO1	7.46e-06	223	65	7	int:EXOSC10
Interaction	ZNF106 interactions	XRN2 MKI67 CREBBP EP300 SLX4	7.57e-06	84	65	5	int:ZNF106
Interaction	WDR3 interactions	XRN2 MYH10 MYH11 MKI67 KIF14 PDE10A	1.28e-05	160	65	6	int:WDR3
Interaction	TERF2 interactions	XRN2 MYH10 BAIAP2L1 ORC6 SYNE2 MKI67 EP300 SLX4	1.32e-05	340	65	8	int:TERF2
Interaction	MYBL2 interactions	BPTF MTA1 RBL1 CREBBP EP300 SLX4	1.37e-05	162	65	6	int:MYBL2
Interaction	PIAS3 interactions	SYNE2 SPOP CREBBP EP300 SLX4	1.38e-05	95	65	5	int:PIAS3
Interaction	RPA4 interactions	STARD9 AHNAK DDX42 ATG2B MKI67 RPL7 SLX4 PRDX6 EXOC8	1.39e-05	452	65	9	int:RPA4
Interaction	RBBP4 interactions	BPTF SP3 MYH10 MTA1 RBL1 DZIP3 KIF14 SPOP CREBBP EP300	1.40e-05	573	65	10	int:RBBP4
Interaction	YY1 interactions	BPTF SP3 KMT2B DDX42 MKI67 DZIP3 CREBBP EP300 SLX4	1.44e-05	454	65	9	int:YY1
Interaction	ECT2 interactions	XRN2 MYH10 MYH11 NPEPPS AHNAK MKI67 KIF14 CMYA5 PLS1 RPL7 NOMO1 ITPR1	2.29e-05	887	65	12	int:ECT2
Interaction	SIRT7 interactions	BPTF XRN2 MYH10 PHF3 NPEPPS AHNAK SYNE2 DDX42 MKI67 KIF14 RPL7	2.34e-05	744	65	11	int:SIRT7
Interaction	CTBP2 interactions	MTA1 BAZ2B NPEPPS MKI67 DZIP3 CREBBP EP300 PRDX6	2.43e-05	370	65	8	int:CTBP2
Interaction	SLFN11 interactions	BDP1 BPTF MYH10 MYH11 DDX42 MKI67 KIF14 KDM2A	2.72e-05	376	65	8	int:SLFN11
Interaction	RCOR1 interactions	MYH10 MTA1 KMT2B AHNAK ATG2B MKI67 DZIP3 RABGAP1 NEK9	2.81e-05	494	65	9	int:RCOR1
Interaction	AURKB interactions	XRN2 MYH10 MYH11 AHNAK MKI67 KIF14 SPOP CRYBG3 CMYA5 EP300 RPL7	2.88e-05	761	65	11	int:AURKB
Interaction	BRCA1 interactions	BPTF XRN2 MYH10 RBL1 NPEPPS AHNAK DDX42 MKI67 DZIP3 CREBBP EP300 RPL7 SLX4 ITPR1	3.55e-05	1249	65	14	int:BRCA1
Interaction	CCND1 interactions	BAIAP2L1 RBL1 MKI67 DZIP3 KDM2A CREBBP EP300	3.71e-05	286	65	7	int:CCND1
Interaction	PML interactions	SP3 KMT2B BAIAP2L1 PHF3 AHNAK SYNE2 DDX42 KIF14 CREBBP EP300 RPL7 SLX4	3.77e-05	933	65	12	int:PML
Interaction	SUMO1 interactions	SP3 MKI67 KIF14 SPOP CREBBP EP300 SLX4	3.79e-05	287	65	7	int:SUMO1
Interaction	ZNF512B interactions	BPTF MYH10 MTA1 KMT2B KDM2A SLX4	4.02e-05	196	65	6	int:ZNF512B
Interaction	HOXB4 interactions	HOXD10 CREBBP EP300	4.09e-05	21	65	3	int:HOXB4
Interaction	CIT interactions	BPTF XRN2 MYH10 MYH11 NPEPPS AHNAK SYNE2 DDX42 MKI67 KIF14 KDM2A CMYA5 PLS1 RPL7 PRDX6	4.49e-05	1450	65	15	int:CIT
Interaction	E2F1 interactions	SP3 MTA1 RBL1 KDM2A CREBBP EP300	4.50e-05	200	65	6	int:E2F1
Interaction	MFAP1 interactions	BDP1 STAC3 DDX42 KIF14 SPOP EP300 SLX4	4.52e-05	295	65	7	int:MFAP1
Interaction	TPX2 interactions	BPTF PHF3 MKI67 KIF14 EP300 SLX4	5.02e-05	204	65	6	int:TPX2
Interaction	DEAF1 interactions	SP3 RBL1 CREBBP EP300	5.41e-05	64	65	4	int:DEAF1
Interaction	HOXD10 interactions	HOXD10 CREBBP EP300	5.42e-05	23	65	3	int:HOXD10
Interaction	FGD5 interactions	MYH10 MYH11 AHNAK RPL7 NOMO3 NOMO1	5.45e-05	207	65	6	int:FGD5
Interaction	DEK interactions	BPTF MYH10 KIF14 SPOP CREBBP EP300	5.75e-05	209	65	6	int:DEK
Interaction	SMC1A interactions	BPTF MTA1 MKI67 DZIP3 KIF14 NEK9 EP300 SLX4	5.75e-05	418	65	8	int:SMC1A
Interaction	NR6A1 interactions	RBL1 CREBBP EP300	6.18e-05	24	65	3	int:NR6A1
Interaction	NONO interactions	MYH10 DDX42 DZIP3 PER1 KIF14 SPOP CREBBP EP300 SLX4	6.36e-05	549	65	9	int:NONO
Interaction	YWHAZ interactions	BDP1 MYH10 MYH11 BAIAP2L1 PHF3 STARD9 SULT1C3 SYNE2 KIF14 SPOP CWF19L1 EP300 EXOC8 ITPR1	6.43e-05	1319	65	14	int:YWHAZ
Interaction	NDC80 interactions	PHF3 SYNE2 DDX42 DZIP3 KIF14 PLS1 EXOC8	6.43e-05	312	65	7	int:NDC80
Interaction	CHMP4C interactions	MYH10 MYH11 BAZ2B STARD9 NPEPPS AHNAK MKI67 PLS1 RPL7 PRDX6	6.53e-05	687	65	10	int:CHMP4C
Interaction	TERF2IP interactions	BPTF XRN2 KMT2B PHF3 DDX42 MKI67 CREBBP SLX4 PRDX6	6.63e-05	552	65	9	int:TERF2IP
Interaction	RBM17 interactions	BDP1 XRN2 DDX42 MKI67 KIF14 EP300	7.26e-05	218	65	6	int:RBM17
Interaction	H2BC21 interactions	BPTF MTA1 KMT2B PHF3 AHNAK MKI67 DZIP3 KDM2A CREBBP EP300	7.28e-05	696	65	10	int:H2BC21
Interaction	SFPQ interactions	SP3 ORC6 DDX42 DZIP3 PER1 KIF14 SPOP EP300 SLX4	7.72e-05	563	65	9	int:SFPQ
Interaction	FIP1L1 interactions	BPTF DDX42 MKI67 KIF14 SPOP EP300	8.64e-05	225	65	6	int:FIP1L1
Interaction	EEF2 interactions	NOMO2 AHNAK KIF14 SPOP SLFN14 CREBBP EP300 RPL7 SLX4	1.07e-04	588	65	9	int:EEF2
Interaction	PPIA interactions	BPTF BAIAP2L1 PHF3 STARD9 AHNAK MKI67 KIF14 KDM2A CRYBG3 SLX4 PRDX6	1.16e-04	888	65	11	int:PPIA
Interaction	TCF12 interactions	RBL1 CREBBP EP300 SLX4 EXOC8	1.16e-04	148	65	5	int:TCF12
Interaction	EP300 interactions	SP3 XRN2 MYH10 MTA1 HOXD10 RBL1 DDX42 KIF14 KDM2A TTC5 CREBBP NEK9 CWF19L1 EP300	1.23e-04	1401	65	14	int:EP300
Interaction	NKRF interactions	XRN2 MKI67 KIF14 EP300 RPL7 SLX4	1.35e-04	244	65	6	int:NKRF
Interaction	EIF3D interactions	MTA1 MKI67 KIF14 DOCK6 CREBBP EP300	1.35e-04	244	65	6	int:EIF3D
Interaction	CHD3 interactions	BPTF XRN2 MYH10 MTA1 DDX42 MKI67 SPOP CREBBP EP300 RPL7	1.45e-04	757	65	10	int:CHD3
Interaction	RALY interactions	BPTF XRN2 KIF14 SPOP CWF19L1 EP300 RPL7	1.46e-04	356	65	7	int:RALY
Interaction	H3C14 interactions	MYH10 MTA1 KMT2B KDM2A EP300	1.48e-04	156	65	5	int:H3C14
Interaction	NEUROD1 interactions	RBL1 CREBBP EP300	1.49e-04	32	65	3	int:NEUROD1
Interaction	ASF1A interactions	BDP1 XRN2 MTA1 KMT2B PHF3 EP300	1.50e-04	249	65	6	int:ASF1A
Interaction	ARSF interactions	SCYL3 EP300 EXOC8	1.63e-04	33	65	3	int:ARSF
Interaction	CEBPB interactions	BPTF SP3 XRN2 MTA1 NPEPPS AHNAK DDX42 MKI67 KIF14 OGA CREBBP EP300 RPL7 PRDX6	1.67e-04	1443	65	14	int:CEBPB
Interaction	NUP43 interactions	BPTF XRN2 MTA1 KMT2B BAZ2B SYNE2 MKI67 KDM2A SLX4	1.70e-04	625	65	9	int:NUP43
Interaction	XRCC6 interactions	BPTF MYH10 MTA1 ORC6 PHF3 NPEPPS DDX42 MKI67 KIF14 CREBBP EP300	1.70e-04	928	65	11	int:XRCC6
Interaction	SP1 interactions	SP3 MYH10 MYH11 RBL1 MKI67 CREBBP EP300	1.70e-04	365	65	7	int:SP1
Interaction	YWHAH interactions	MYH11 BAIAP2L1 PHF3 STARD9 AHNAK SYNE2 KIF14 SPOP CRYBG3 DOCK6 GEN1 CREBBP	1.84e-04	1102	65	12	int:YWHAH
Interaction	FBXO42 interactions	BDP1 XRN2 KIF14 RABGAP1 CRYBG3 RPL7	1.86e-04	259	65	6	int:FBXO42
Interaction	CHD4 interactions	BPTF XRN2 MYH10 MTA1 AHNAK DDX42 MKI67 DZIP3 EP300 RPL7 SLX4	1.87e-04	938	65	11	int:CHD4
Interaction	C3orf62 interactions	RBL1 CREBBP EP300	1.95e-04	35	65	3	int:C3orf62
Interaction	TNFSF10 interactions	SP3 CREBBP NOMO1	1.95e-04	35	65	3	int:TNFSF10
Interaction	ASH2L interactions	BDP1 KMT2B MKI67 KIF14 KDM2A EP300	2.11e-04	265	65	6	int:ASH2L
Interaction	E2F5 interactions	RBL1 CREBBP EP300	2.12e-04	36	65	3	int:E2F5
Interaction	HOXB2 interactions	SYNE2 CREBBP EP300	2.12e-04	36	65	3	int:HOXB2
Interaction	CBX3 interactions	KMT2B PHF3 DDX42 MKI67 KIF14 KDM2A CWF19L1 EP300 SLX4	2.17e-04	646	65	9	int:CBX3
Interaction	SETD1A interactions	KMT2B AHNAK MKI67 CREBBP EP300	2.21e-04	170	65	5	int:SETD1A
Interaction	CITED1 interactions	RBL1 CREBBP EP300	2.30e-04	37	65	3	int:CITED1
Interaction	PARP1 interactions	BPTF MYH10 MTA1 PHF3 STARD9 MKI67 KDM2A CREBBP PLS1 CWF19L1 EP300 SLX4 PRDX6	2.50e-04	1316	65	13	int:PARP1
Interaction	BRMS1 interactions	DZIP3 SPOP CREBBP EP300	2.62e-04	96	65	4	int:BRMS1
Interaction	RB1 interactions	BDP1 SP3 RBL1 DZIP3 KDM2A CREBBP EP300	2.72e-04	394	65	7	int:RB1
Interaction	ATG16L1 interactions	XRN2 BAIAP2L1 DDX42 ATG2B KIF14 DHX32 RABGAP1 CRYBG3 PLS1 CWF19L1 RPL7 ITPR1	2.97e-04	1161	65	12	int:ATG16L1
Interaction	MTA1 interactions	BPTF MYH10 MTA1 DZIP3 KIF14 EP300	3.00e-04	283	65	6	int:MTA1
Interaction	AR interactions	XRN2 MYH10 MTA1 RBL1 PHF3 DDX42 SPOP TTC5 CREBBP NEK9 EP300	3.03e-04	992	65	11	int:AR
Interaction	TP53BP1 interactions	RBL1 NPEPPS DDX42 KDM2A SPOP CREBBP EP300 SLX4	3.05e-04	533	65	8	int:TP53BP1
Interaction	RBBP5 interactions	KMT2B BAZ2B MKI67 KDM2A CREBBP EP300	3.23e-04	287	65	6	int:RBBP5
Interaction	NUPR1 interactions	XRN2 MYH10 AHNAK DDX42 MKI67 KIF14 KDM2A PLS1 EP300	3.28e-04	683	65	9	int:NUPR1
Interaction	CLOCK interactions	DZIP3 PER1 CREBBP EP300	3.30e-04	102	65	4	int:CLOCK
Interaction	RNF38 interactions	MYH10 AHNAK DZIP3 RPL7	3.30e-04	102	65	4	int:RNF38
Interaction	SMC3 interactions	MYH11 MTA1 MKI67 DZIP3 KIF14 EP300 SLX4	3.35e-04	408	65	7	int:SMC3
Interaction	KDM2A interactions	KMT2B KDM2A CREBBP EP300	3.43e-04	103	65	4	int:KDM2A
Interaction	STXBP2 interactions	MKI67 KIF14 EP300 EXOC8	3.43e-04	103	65	4	int:STXBP2
Interaction	TRIM21 interactions	BPTF AHNAK DZIP3 KIF14 SPOP EP300 RPL7 PRDX6 EXOC8	3.50e-04	689	65	9	int:TRIM21
Interaction	CUL7 interactions	BPTF XRN2 NPEPPS AHNAK SYNE2 DDX42 MKI67 DOCK6 RPL7 PRDX6	3.52e-04	845	65	10	int:CUL7
Interaction	SNAI1 interactions	MYH10 MTA1 NPEPPS SPOP CREBBP EP300 RPL7 PRDX6	3.58e-04	546	65	8	int:SNAI1
Interaction	HOXB3 interactions	CREBBP EP300	3.63e-04	9	65	2	int:HOXB3
Interaction	ARGFX interactions	CREBBP EP300	3.63e-04	9	65	2	int:ARGFX
Interaction	PPP1CA interactions	DDX42 MKI67 KIF14 SPOP RABGAP1 CREBBP NEK9 EP300 RPL7	3.76e-04	696	65	9	int:PPP1CA
Interaction	KRT18 interactions	XRN2 UPF2 KIF14 SPOP CRYBG3 EP300 EXOC8	3.94e-04	419	65	7	int:KRT18
Cytoband	10q26.2	MKI67 DHX32	1.33e-04	12	66	2	10q26.2
Cytoband	Ensembl 112 genes in cytogenetic band chr16p13	MYH11 CREBBP SLX4 NOMO3 NOMO1	3.77e-04	426	66	5	chr16p13
Cytoband	16p13.11	MYH11 NOMO1	5.05e-04	23	66	2	16p13.11
Cytoband	16p12.3	NOMO2 IQCK	1.11e-03	34	66	2	16p12.3
GeneFamily	PHD finger proteins	BPTF KMT2B BAZ2B PHF3 KDM2A	3.55e-06	90	47	5	88
GeneFamily	Zinc fingers CXXC-type	KMT2B KDM2A	4.29e-04	12	47	2	136
GeneFamily	Myosin heavy chains	MYH10 MYH11	6.80e-04	15	47	2	1098
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	CREBBP EP300	8.77e-04	17	47	2	486
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	CREBBP EP300	9.85e-04	18	47	2	91
GeneFamily	Kinesins\|Pleckstrin homology domain containing	STARD9 KIF14	6.37e-03	46	47	2	622
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	BDP1 MTA1	8.38e-03	53	47	2	532
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	MKI67 DZIP3 ITPR1	1.16e-02	181	47	3	694
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	BPTF SP3 ATP2C1 UPF2 BAZ2B PHF3 NPEPPS SYNE2 DDX42 KIF14 SPOP RABGAP1 CRYBG3 CREBBP ITPR1	2.05e-09	856	65	15	M4500
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	BPTF KMT2B NPEPPS ATG2B KIF14 KDM2A CREBBP EP300	1.53e-08	180	65	8	M8239
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	KMT2B UPF2 BAZ2B ORC6 PHF3 PER1 KDM2A RABGAP1 ITGA2 PDE10A OGA CREBBP EP300	9.41e-08	822	65	13	M6782
Coexpression	PGF_UP.V1_UP	SP3 UPF2 BAZ2B PHF3 SYNE2 ITGA2 CRYBG3	4.60e-07	190	65	7	M2674
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	BPTF SP3 BAZ2B PHF3 MKI67 KIF14 SPOP CREBBP	7.69e-07	300	65	8	M8702
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	BPTF UPF2 BAZ2B PHF3 NPEPPS KIF14 SPOP RABGAP1 CREBBP	2.17e-06	466	65	9	M13522
Coexpression	MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS	BDP1 BPTF BAZ2B SYNE2 MKI67	3.00e-06	90	65	5	M39250
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	BDP1 BPTF MYH10 BAZ2B PHF3 SYNE2 MKI67 KIF14 ZNF407 ITPR1	4.67e-06	656	65	10	M18979
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	BDP1 BPTF SP3 XRN2 PHF3 AHNAK DZIP3 KDM2A OGA CREBBP NEK9 EP300 RPL7 ITPR1	1.39e-05	1492	65	14	M40023
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	SP3 PHF3 MKI67 KIF14 SPOP	3.06e-05	145	65	5	M1810
Coexpression	EIF4E_DN	MYH10 UPF2 NPEPPS OGA	1.13e-04	100	65	4	M2790
Coexpression	GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN	UPF2 RBL1 KIF14 SPOP RABGAP1	1.31e-04	197	65	5	M5210
Coexpression	GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP	HOXD10 BAZ2B PDE10A DOCK6 CWF19L1	1.37e-04	199	65	5	M4886
Coexpression	GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN	XRN2 SPOP TTC5 RPL7 PRDX6	1.37e-04	199	65	5	M8481
Coexpression	GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_DN	PER1 DHX32 SPOP NEK9 NOMO1	1.37e-04	199	65	5	M4147
Coexpression	GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_DN	STAC3 MKI67 KIF14 DHX32 ITGA2	1.40e-04	200	65	5	M9302
Coexpression	GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	STARD9 SCYL3 GEN1 CREBBP TEX44	1.40e-04	200	65	5	M7532
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	ATP2C1 UPF2 NPEPPS SYNE2 SCYL3 DDX42 DZIP3 SPOP NEK9 NME8 PRDX6	1.82e-04	1215	65	11	M41122
Coexpression	DAZARD_RESPONSE_TO_UV_SCC_DN	BAZ2B PHF3 KDM2A SPOP	1.94e-04	115	65	4	M7484
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	BPTF XRN2 MYH10 UPF2 RBL1 SYNE2 MKI67 ZNF407 KDM2A DHX32 OGA EP300	1.82e-07	595	64	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	BDP1 BPTF MYH10 UPF2 SYNE2 STAC3 MKI67 ZNF407 OGA IQCK	1.74e-05	629	64	10	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	BDP1 BPTF MYH10 ANK2 UNCX UPF2 ORC6 RBL1 PHF3 SYNE2 MKI67 DZIP3 DHX32 GEN1 IQCK	2.16e-05	1459	64	15	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000	SP3 SYNE2 DZIP3 PDE10A CREBBP	4.06e-05	127	64	5	gudmap_developingGonad_e16.5_epididymis_1000_k4
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	BDP1 BPTF MYH10 ANK2 UPF2 ORC6 RBL1 PHF3 SYNE2 MKI67 DZIP3 DHX32 GEN1	7.99e-05	1257	64	13	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000	SP3 SYNE2 DDX42 PDE10A CREBBP PRDX6	1.79e-04	275	64	6	gudmap_developingGonad_e14.5_ epididymis_1000_k3
ToppCell	(1)_T_cell-(11)_Activated_CD4_T\|(1)_T_cell / shred on Cell_type and subtype	AHNAK SYNE2 PER1 KDM2A CRYBG3 RPL7	4.91e-07	198	66	6	4b9ad91342f622c63e476d4f6a0ae5bf282a7ef5
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 BPTF PHF3 AHNAK SYNE2 KDM2A	5.21e-07	200	66	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	368C-Myeloid-Dendritic-cDC_proliferating_1\|368C / Donor, Lineage, Cell class and subclass (all cells)	ORC6 RBL1 MKI67 KIF14 GEN1	6.92e-06	179	66	5	ec69e1dd897414033ba5b007aa82655a79adca6c
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	ORC6 RBL1 MKI67 KIF14 GEN1	8.12e-06	185	66	5	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	368C-Myeloid-Dendritic-cDC_proliferating_1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ORC6 RBL1 MKI67 KIF14 GEN1	8.34e-06	186	66	5	799903b68bc6f6205d004b44c603424b0d5f7c32
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	SP3 UPF2 RABGAP1 CREBBP EP300	8.34e-06	186	66	5	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ATP2C1 NPEPPS SYNE2 ZNF407 ITPR1	8.78e-06	188	66	5	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYL4 PHF3 PER1 KDM2A OGA	9.48e-06	191	66	5	1ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	BDP1 BPTF XRN2 MYH10 PHF3	9.72e-06	192	66	5	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ORC6 RBL1 MKI67 KIF14 GEN1	9.97e-06	193	66	5	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	BDP1 BPTF XRN2 MYH10 PHF3	9.97e-06	193	66	5	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 UPF2 AHNAK GEN1 ITPR1	1.05e-05	195	66	5	481989d2e5bd2582da3d86b0155c4d6615317067
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 UPF2 AHNAK GEN1 ITPR1	1.05e-05	195	66	5	6108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCell	Caecum-(1)_T_cell-(18)_cycling_gd_T\|Caecum / shred on region, Cell_type, and subtype	ORC6 MKI67 KIF14 ITGA2 SLX4	1.13e-05	198	66	5	64278d8831c81874937e76b561c53928dfc437c5
ToppCell	Caecum-T_cell-cycling_gd_T\|Caecum / Region, Cell class and subclass	ORC6 MKI67 KIF14 ITGA2 SLX4	1.13e-05	198	66	5	5b719b67f8384863077070e1eb7e04a320e6dab4
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 BPTF PHF3 SYNE2 ZNF407	1.16e-05	199	66	5	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	BPTF BAZ2B PHF3 SYNE2 DZIP3	1.16e-05	199	66	5	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell\|10w / Sample Type, Dataset, Time_group, and Cell type.	ORC6 SYNE2 MKI67 KIF14 GEN1	1.18e-05	200	66	5	8f8b8c225cdc79baf16fe04be89bdb65e404a055
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells\|10w / Sample Type, Dataset, Time_group, and Cell type.	ORC6 SYNE2 MKI67 KIF14 GEN1	1.18e-05	200	66	5	a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	MYL4 AHNAK DZIP3 PER1 ITPR1	1.18e-05	200	66	5	0d76b006d8e8b32174e65e400acd0674354b962c
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2\|World / Primary Cells by Cluster	BAZ2B ORC6 SYNE2 MKI67 ITGA2	1.18e-05	200	66	5	4923d7a4f00853c4d76fc1cc0fa82d522a2302e7
ToppCell	Non-neuronal-Dividing-IPC\|World / Primary Cells by Cluster	ORC6 SYNE2 MKI67 KIF14 ITGA2	1.18e-05	200	66	5	971533181daa1bfac1f1b8c507d2013f891f9078
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	MYL4 AHNAK DZIP3 PER1 ITPR1	1.18e-05	200	66	5	cc8368665bc6bb7c4f39632ccff07ceaa98a7b65
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2-5\|World / Primary Cells by Cluster	BAZ2B ORC6 SYNE2 MKI67 ITGA2	1.18e-05	200	66	5	dc1c1506823eaa105f1532c6b5d4efa14e788314
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	BPTF PHF3 AHNAK SYNE2 KDM2A	1.18e-05	200	66	5	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ORC6 RBL1 MKI67 KIF14 GEN1	1.18e-05	200	66	5	af3dc76b4507bf4edd265169f5dfbbb8a19eb394
ToppCell	390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|390C / Donor, Lineage, Cell class and subclass (all cells)	MYL4 ORC6 MKI67 KIF14	9.13e-05	159	66	4	0fbfdb18b7ed4bde077add13f2b3636e144b254f
ToppCell	PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IFNK MKI67 KIF14 PRDX6	1.10e-04	167	66	4	a90f905ef38437752e2b0b71bd0322a184de1861
ToppCell	mild_COVID-19_(asymptomatic)-RBC\|World / disease group, cell group and cell class (v2)	MYL4 SPOP ST7L GEN1	1.15e-04	169	66	4	2bda6ab3f32e05cb7daf91eb7c39b4fcc9ae91bb
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH10 MKI67 KIF14 GEN1	1.15e-04	169	66	4	563c267edaade0e5df192ad953801ef9768d4270
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYNE2 MKI67 DOCK6 NOMO3	1.24e-04	172	66	4	eee45759284baa3ed77da6a5fbcc4f8f6c553106
ToppCell	PND28-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RBL1 STAC3 MKI67 KIF14	1.24e-04	172	66	4	eba1568d4307e91c94fc616549057cbed8df5840
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ORC6 SYNE2 MKI67 KIF14	1.26e-04	173	66	4	b7e0193fd4983cb38d1bee441f608f73ee8743b9
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNE2 MKI67 KIF14 ITGA2	1.29e-04	174	66	4	94575a605c725de83f66a6cf7df9d7bb360ffc56
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNE2 MKI67 KIF14 ITGA2	1.29e-04	174	66	4	40c81ab36d7931e271e20d7d56fed32463c75f41
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNE2 MKI67 KIF14 ITGA2	1.29e-04	174	66	4	b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	MYL4 STARD9 STAC3 PLS1	1.32e-04	175	66	4	2812ac2ef41d245db544697fb6da1883361c96e8
ToppCell	368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	ORC6 MKI67 KIF14 GEN1	1.32e-04	175	66	4	74800a10f5ff25d5414fbccb0668f92ff077d1cc
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH11 MYL4 SLX4 ITPR1	1.35e-04	176	66	4	4ed73c73972334f6dc4229920205547823252fa0
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	UPF2 DZIP3 RABGAP1 OGA	1.38e-04	177	66	4	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ORC6 MKI67 KIF14 GEN1	1.47e-04	180	66	4	f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 SULT1C3 SYNE2 ITGA2	1.60e-04	184	66	4	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XRN2 PHF3 AHNAK EP300	1.60e-04	184	66	4	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	Dividing_Macrophages-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	ORC6 MKI67 KIF14 GEN1	1.60e-04	184	66	4	f15ce786d25c6546804a6d1efcc2ad645f2ef54e
ToppCell	droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK2 HOXD10 PDE10A DOCK6	1.63e-04	185	66	4	3a4ae836e882e8d29eb0a2dfab5677f10f2d365f
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	BPTF MYH10 BAZ2B SYNE2	1.63e-04	185	66	4	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK2 HOXD10 PDE10A DOCK6	1.63e-04	185	66	4	224f0b022c21dd40bf1f7503f00b3107ef958975
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	UPF2 AHNAK RABGAP1 GEN1	1.67e-04	186	66	4	55b239834b96b1f7787ec77a7d19796d617bbbf0
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UPF2 SYNE2 ITGA2 CREBBP	1.70e-04	187	66	4	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ\|B_lymphocytes / Location, Cell class and cell subclass	BAIAP2L1 SYNE2 STAC3 PRDX6	1.70e-04	187	66	4	457eb3791a8c5458d81833e0701ac5a9bfdee2bf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ORC6 MKI67 KIF14 GEN1	1.70e-04	187	66	4	057569c9437219ecc396aa6e673b1178a2273837
ToppCell	droplet-Marrow-nan-3m-Hematologic-erythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH10 ORC6 MKI67 GEN1	1.77e-04	189	66	4	8a38baee58a27c2fa3f4bd131ab9f15723ed9295
ToppCell	PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	SULT1C3 MKI67 KIF14 PLS1	1.77e-04	189	66	4	c8b8f860aaf6c73863cd79941db6b469c830ef06
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BPTF MYH10 MYH11 AHNAK	1.81e-04	190	66	4	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ORC6 RBL1 MKI67 KIF14	1.81e-04	190	66	4	b65383e256b04122500b742caeed0b807793851e
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ORC6 RBL1 MKI67 KIF14	1.81e-04	190	66	4	89095d3e023269d89c82e3a73550f869e3f34201
ToppCell	Dividing_Macrophages-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	ORC6 STAC3 MKI67 KIF14	1.85e-04	191	66	4	3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ORC6 RBL1 MKI67 KIF14	1.85e-04	191	66	4	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	Mild-T/NK_proliferative\|World / Disease group and Cell class	ORC6 MKI67 KIF14 GEN1	1.85e-04	191	66	4	9dba5526fd5ea8065ad305feb2ee562335f887c6
ToppCell	(3)_Macrophage_Dividing\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	ORC6 STAC3 MKI67 KIF14	1.85e-04	191	66	4	b42f0b89bb94fd43786ff50f1caeb3ebfbbb43fd
ToppCell	Control-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	NOMO2 PDE10A NOMO3 NOMO1	1.88e-04	192	66	4	7e89b9125e8b85f6be85eeccef5c8644647ab0e1
ToppCell	facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ORC6 MKI67 KIF14 GEN1	1.88e-04	192	66	4	e8d47504b744040a762ec9b670a66cc060b2ae86
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 NPEPPS AHNAK ITPR1	1.92e-04	193	66	4	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH10 MYH11 MKI67 KIF14	1.92e-04	193	66	4	a332dfdcc48c405020014e644aa4d14fda98cc86
ToppCell	Severe_COVID-19-Myeloid-proliferating_Myeloid_cells\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	ORC6 MKI67 KIF14 GEN1	1.92e-04	193	66	4	0d85025690c9cd545cba30abc38acbdd6a39b153
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH10 MYH11 ANK2 ORC6	1.92e-04	193	66	4	f25bdd10ef531b8d8441ea84573078b4b1b0f105
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ORC6 MKI67 KIF14 GEN1	1.96e-04	194	66	4	cb39850e9577015b6b9834e98c36b412bae7d462
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ORC6 STAC3 MKI67 KIF14	1.96e-04	194	66	4	e5b81a8e52259a54a911c1c2ac932c98c988318d
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ORC6 MKI67 KIF14 GEN1	1.96e-04	194	66	4	408597c9aa302a44b112c1d612c21fbb0227a82a
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ORC6 MKI67 KIF14 GEN1	1.96e-04	194	66	4	193cc20fefbd795a4ad59e401a95af47d30603e7
ToppCell	BAL-Severe-Myeloid-Myeloid\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ORC6 MKI67 KIF14 GEN1	1.96e-04	194	66	4	2360b5f995b360419de41612368cab9fb61781a1
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ORC6 MKI67 KIF14 GEN1	1.96e-04	194	66	4	903ae11708b0cb24538c6982abd57fe6fa95b8d3
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast\|World / Lineage, cell class and subclass	MYH10 MYL4 MKI67 KIF14	1.96e-04	194	66	4	008bb0072f414a48d052429101bdc990ee4f80c2
ToppCell	BAL-Severe-Myeloid-Myeloid\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ORC6 MKI67 KIF14 GEN1	1.96e-04	194	66	4	58406502a8cbcc3037f79a1b6a683df408297ae5
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	MYH11 MYL4 ANK2 CMYA5	1.96e-04	194	66	4	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ORC6 RBL1 MKI67 KIF14	2.00e-04	195	66	4	1a5e814e12fe37287dbfc58189e1958e2c76b5da
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PHF3 SYNE2 OGA NEK9	2.00e-04	195	66	4	ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCell	COVID-19-lung-Proliferative_fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	MYH10 ORC6 MKI67 KIF14	2.04e-04	196	66	4	2ce8a787f2731faa913d20342d73041d59468f27
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ORC6 RBL1 MKI67 KIF14	2.04e-04	196	66	4	1964c5003a0cb84539850a7cfe3bbb0e23a61d2d
ToppCell	P07-Mesenchymal-myocytic_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYH10 MYH11 ANK2 PDE10A	2.08e-04	197	66	4	378299fe2ec6ed2fc858febb78ff1ac0898e457d
ToppCell	Mild\|World / Condition, Lineage, Cell class and cell subclass	BDP1 PHF3 STAC3 SPOP	2.08e-04	197	66	4	476b0d0389f9fcd4614f6bb1f494281f467f6730
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYH10 ORC6 MKI67 KIF14	2.08e-04	197	66	4	196eaecef7003ed83f323c1f157c6a3594650097
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	PHF3 PER1 KDM2A OGA	2.08e-04	197	66	4	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	P07-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYH10 MYH11 ANK2 PDE10A	2.08e-04	197	66	4	b1135378d768fbbe62a75747d1e8653d35252187
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	BDP1 UPF2 AHNAK OGA	2.08e-04	197	66	4	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	erythropoietic-Polychromatic_Erythroblast\|World / Lineage and Cell class	MYH10 MYL4 ORC6 MKI67	2.08e-04	197	66	4	604fcbf47f073c2af344e1b16b615a78ef838dc9
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	PHF3 PER1 KDM2A OGA	2.12e-04	198	66	4	44417089b62056269cac38d3134ff209c05b7007
ToppCell	normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ\|B_lymphocytes / Location, Cell class and cell subclass	ORC6 MKI67 KIF14 PRDX6	2.12e-04	198	66	4	41e4bc7964a4895dd05bc62f0ef632ce9c89e34f
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ORC6 MKI67 KIF14 GEN1	2.12e-04	198	66	4	f088badb90c6c2d916195f5649eda102119c9ac6
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PHF3 PER1 KDM2A OGA	2.12e-04	198	66	4	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	BPTF ANK2 BAZ2B OGA	2.12e-04	198	66	4	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	COVID-19_Severe-Neu_4\|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients	RBL1 MKI67 KIF14 RPL7	2.12e-04	198	66	4	bfdddddef9f3f0eb6af013873dec4e06b7c78c58
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYH10 ORC6 MKI67 KIF14	2.12e-04	198	66	4	36897e17de2e22ee6b23920ee6e60931903f3e5c
ToppCell	Sigmoid-Dendritic_cell-cycling_DCs\|Sigmoid / Region, Cell class and subclass	ORC6 STAC3 MKI67 KIF14	2.16e-04	199	66	4	bd6f8c0f79e9a94cc0f8c6105d38851463de821c
ToppCell	COVID-19_Severe-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	RBL1 MKI67 KIF14 RPL7	2.16e-04	199	66	4	0e327479bbda5a16643cf317d293a2918d619f87
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ORC6 SYNE2 MKI67 KIF14	2.16e-04	199	66	4	305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ORC6 SYNE2 MKI67 KIF14	2.16e-04	199	66	4	101f78fe6dd1bf9e2e4dd5ad8a970312b3540927
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYH10 MYH11 BAZ2B CMYA5	2.16e-04	199	66	4	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ORC6 SYNE2 MKI67 KIF14	2.16e-04	199	66	4	e0fcec796afe75e42467ca86355b9fc5aa9ae0a1
ToppCell	Sigmoid-(5)_Dendritic_cell-(52)_cycling_DCs\|Sigmoid / shred on region, Cell_type, and subtype	ORC6 STAC3 MKI67 KIF14	2.16e-04	199	66	4	8ee78a39729633bcbb3ab17e1dfaca33f38db569
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BDP1 BPTF PHF3 AHNAK SYNE2 OGA	4.05e-08	49	44	6	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BDP1 BPTF SYNE2 OGA	4.90e-05	50	44	4	GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1
Drug	Methylergometrine maleate [113-42-8]; Down 200; 8.8uM; PC3; HT_HG-U133A	MTA1 MYL4 PHF3 DZIP3 OGA CWF19L1 ITPR1	1.44e-06	193	66	7	6704_DN
Drug	Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A	BPTF MYL4 MKI67 PER1 RABGAP1 OGA	1.14e-05	174	66	6	1302_UP
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA	PHF3 AHNAK KDM2A SPOP DOCK6 EP300	1.61e-05	185	66	6	1049_DN
Drug	LY294002; Up 200; 10uM; PC3; HT_HG-U133A	MYL4 AHNAK ZNF407 ITGA2 PDE10A ST7L	1.93e-05	191	66	6	5970_UP
Drug	Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HG-U133A	ATP2C1 MYL4 BAZ2B PHF3 KDM2A DOCK6	2.10e-05	194	66	6	1947_DN
Drug	Quinic acid [86-68-0]; Down 200; 19.6uM; HL60; HT_HG-U133A	MYL4 AHNAK ITGA2 ST7L PLS1 IQCK	2.23e-05	196	66	6	2978_DN
Drug	Epitiostanol [2363-58-8]; Up 200; 13uM; HL60; HT_HG-U133A	MTA1 MYL4 DZIP3 ITGA2 PDE10A ST7L	2.29e-05	197	66	6	2922_UP
Drug	Enalapril maleate [76095-16-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A	RBL1 PHF3 DZIP3 DOCK6 CWF19L1 EP300	2.36e-05	198	66	6	7428_UP
Drug	Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; HL60; HT_HG-U133A	MYL4 ANK2 PHF3 KDM2A DOCK6 NEK9	2.36e-05	198	66	6	2200_DN
Drug	Diprophylline [479-18-5]; Up 200; 15.8uM; PC3; HT_HG-U133A	MTA1 MYL4 SCYL3 PER1 RABGAP1 EP300	2.43e-05	199	66	6	1811_UP
Disease	obsolete_red blood cell distribution width	SP3 XRN2 KMT2B BAZ2B RBL1 SYNE2 ZNF407 DHX32 ST7L SLFN14 DOCK6 PLS1 EP300	4.38e-06	1347	63	13	EFO_0005192
Disease	Menke-Hennekam syndrome	CREBBP EP300	4.49e-06	2	63	2	cv:C5681632
Disease	Rubinstein-Taybi syndrome (implicated_via_orthology)	CREBBP EP300	4.49e-06	2	63	2	DOID:1933 (implicated_via_orthology)
Disease	Rubinstein-Taybi syndrome	CREBBP EP300	4.49e-06	2	63	2	cv:C0035934
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	4.49e-06	2	63	2	C4551859
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	4.49e-06	2	63	2	180849
Disease	Rubinstein-Taybi syndrome due to CREBBP mutations	CREBBP EP300	4.49e-06	2	63	2	cv:C4551859
Disease	Rubinstein-Taybi syndrome (is_implicated_in)	CREBBP EP300	4.49e-06	2	63	2	DOID:1933 (is_implicated_in)
Disease	Rubinstein-Taybi Syndrome	CREBBP EP300	4.49e-06	2	63	2	C0035934
Disease	Malignant neoplasm of breast	ANK2 SYNE2 MKI67 PER1 DHX32 FSCB GEN1 EP300 NME8	4.39e-04	1074	63	9	C0006142
Disease	Leukemia, Myelocytic, Acute	MYH11 CREBBP EP300 SLX4	5.19e-04	173	63	4	C0023467
Disease	level of Sterol ester (27:1/20:3) in blood serum	MYH11 NOMO1	7.49e-04	19	63	2	OBA_2045199
Disease	HDL cholesterol change measurement	SYNE2 DOCK6	1.20e-03	24	63	2	EFO_0007805
Disease	Breast Cancer, Familial	GEN1 SLX4	1.88e-03	30	63	2	C0346153

Protein segments in the cluster

Peptide	Gene	Start	Entry
VKMEAKMEVDQPEPA	EP300	976	Q09472
SPKEMVPAEINTKEM	BDP1	856	A6H8Y1
IGKIEVIPMMPEVKN	CRYBG3	1631	Q68DQ2
KLLEVAKMPPESEVM	BAZ2B	1471	Q9UIF8
QKSEPMEVDEKKPEV	CREBBP	1041	Q92793
MDVSVPKVEGEMKVP	AHNAK	1671	Q09666
DMDVSVPKVEGEMKV	AHNAK	2006	Q09666
DMDVSVPKVEGEMKV	AHNAK	2201	Q09666
EMNIKAPKISMPDLD	AHNAK	3211	Q09666
KDMTPLKPAEMQEAN	DHX32	411	Q7L7V1
PCKEEPMEVDDDMKT	BPTF	1136	Q12830
KMMQAEEAPKTPLQK	ATP2C1	246	P98194
APKAAMQEKEEEPVI	ATG2B	1496	Q96BY7
MQEKEEEPVIKIMVD	ATG2B	1501	Q96BY7
ERMTKPPVQEMVDEL	NOMO3	731	P69849
KMEDDAVPAAKMKIP	IQCK	271	Q8N0W5
PKEKMADEQGDMDLQ	ANK2	2111	Q01484
QKELADVLMDPPMDD	RABGAP1	61	Q9Y3P9
LDEDPQVIEMMADKK	KIF14	181	Q15058
ERMTKPPVQEMVDEL	NOMO2	731	Q5JPE7
GTQTAKEEMEMDPKP	NEK9	946	Q8TD19
TMMNIPPVEKVDKEQ	FSCB	141	Q5H9T9
KQAEPEKEDIMVMDT	ITPR1	966	Q14643
QVQPMVDPKTGEKIM	KIAA2026	1086	Q5HYC2
MKLMDAAELVKQPPD	CWF19L1	246	Q69YN2
NRESKMEPKMEPKVD	DDX42	891	Q86XP3
VGDKKPPESDIIMME	PER1	731	O15534
LPDDLVEVKPKMVMT	PLS1	601	Q14651
IPMMDRDKKDEVPQG	PDE10A	701	Q9Y233
ERMTKPPVQEMVDEL	NOMO1	731	Q15155
VAEEMMPAAEKEEAK	KMT2B	386	Q9UMN6
PKPEEMNVKMLDFET	MYL4	101	P12829
EKKPMKTSPEMDIQN	MKI67	3121	P46013
MEGVEEKKKEVPAVP	RPL7	1	P18124
LAVVNVKDNPPMKDM	EXOC8	236	Q8IYI6
TIPLMIMKPDEKAEV	ITGA2	1116	P17301
GMMQEDIDKVKENPI	DZIP3	541	Q86Y13
RTEMVPKKDDVSPVM	SCYL3	696	Q8IZE3
IKMPDPDFTVNDVKM	KDM2A	86	Q9Y2K7
PEKIMNMIEEIKTPA	BAIAP2L1	236	Q9UHR4
VKMKEHQEDPEMLID	DOCK6	1566	Q96HP0
KMVSNKEMPKEPEDT	CMYA5	2906	Q8N3K9
EMKENEMKPSEARVP	IFNK	141	Q9P0W0
QMEKKMNEPVSGQEP	HOXD10	196	P28358
MDVKLVFVMEGEPPK	GEN1	66	Q17RS7
MDKPEMNVVLKNVKP	NPEPPS	561	P55786
IQKMNPPKFSKVEDM	MYH10	76	P35580
MPAERKKPASMEEKD	UPF2	1	Q9HAU5
VMKEEMKRIKENPPS	SLFN14	741	P0C7P3
MEKKPELFNIMEVDG	SULT1C3	11	Q6IMI6
EAELEMLKMAKPPSD	SYNE2	6571	Q8WXH0
MLKMAKPPSDIQEIE	SYNE2	6576	Q8WXH0
EKKQPDEEPMDMVVE	OGA	456	O60502
EIVEAKMAEELKPMD	OGA	486	O60502
FGEDPPKEMLMDKII	RBL1	661	P28749
MLDPAEKDEKGMPVT	PRDX6	116	P30041
EAPAKEMEKVEEMPH	ORC6	206	Q9Y5N6
EMEKVEEMPHKPQKD	ORC6	211	Q9Y5N6
QEEPKAQGKVEEMPM	STARD9	2266	Q9P2P6
EMENPEMVDLPEKLK	MTA1	86	Q13330
AREENVPKDPQEEMM	SLX4	236	Q8IY92
IQKMNPPKFSKVEDM	MYH11	76	P35749
KDKMSQMASVPEREP	TEX44	131	Q53QW1
PEVEAQVTPGMMKNK	NME8	256	Q8N427
VEINDVEPEVFKEMM	SPOP	241	O43791
MTAPEKPVKQEEMAA	SP3	1	Q02447
EDKPAPKNEDEMMVA	XRN2	66	Q9H0D6
MMADEEEEVKPILQK	TTC5	1	Q8N0Z6
PMKEQEAAMEIQEPA	PHF3	1066	Q92576
EAVKIMRDLMKEFPP	ST7L	311	Q8TDW4
KKDPVMPQNMVPLED	TEX13C	651	A0A0J9YWL9
APVKDKVRKPEEMMS	ZNF407	1171	Q9C0G0
QADKKNPVAAMMEEE	STAC3	196	Q96MF2
PMDPEEIARKELEKM	UNCX	186	A6NJT0